Fate Therapeutics IncNASDAQ:FATE
- LAST PRICE3.8900
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.7700/ 1
- Ask / Lots4.0000/ 3
- Open / Previous Close0.0000 / 3.8900
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FATE |
|---|---|---|
| 09:32 ET | 9738 | 3.84 |
| 09:34 ET | 3384 | 3.815 |
| 09:36 ET | 4826 | 3.8 |
| 09:38 ET | 4258 | 3.81 |
| 09:39 ET | 15856 | 3.82 |
| 09:41 ET | 400 | 3.82 |
| 09:43 ET | 2300 | 3.835 |
| 09:45 ET | 7335 | 3.825 |
| 09:48 ET | 2709 | 3.82 |
| 09:50 ET | 2000 | 3.785 |
| 09:52 ET | 2105 | 3.795 |
| 09:54 ET | 10529 | 3.79 |
| 09:56 ET | 3900 | 3.77 |
| 09:57 ET | 1200 | 3.765 |
| 09:59 ET | 3624 | 3.78 |
| 10:01 ET | 2845 | 3.8 |
| 10:03 ET | 9007 | 3.83 |
| 10:06 ET | 4215 | 3.845 |
| 10:08 ET | 4001 | 3.835 |
| 10:10 ET | 4161 | 3.845 |
| 10:12 ET | 4472 | 3.8 |
| 10:14 ET | 2832 | 3.815 |
| 10:15 ET | 1055 | 3.8 |
| 10:17 ET | 2058 | 3.815 |
| 10:19 ET | 2395 | 3.825 |
| 10:21 ET | 4642 | 3.8 |
| 10:24 ET | 1700 | 3.8 |
| 10:26 ET | 2638 | 3.8 |
| 10:28 ET | 2765 | 3.79 |
| 10:30 ET | 5008 | 3.78 |
| 10:32 ET | 2599 | 3.79 |
| 10:33 ET | 322 | 3.79 |
| 10:35 ET | 1752 | 3.785 |
| 10:37 ET | 1032 | 3.785 |
| 10:39 ET | 733 | 3.785 |
| 10:42 ET | 3717 | 3.805 |
| 10:44 ET | 900 | 3.79 |
| 10:46 ET | 6213 | 3.815 |
| 10:48 ET | 1764 | 3.825 |
| 10:50 ET | 507 | 3.825 |
| 10:51 ET | 2032 | 3.835 |
| 10:53 ET | 400 | 3.835 |
| 10:55 ET | 400 | 3.835 |
| 10:57 ET | 1634 | 3.82 |
| 11:00 ET | 600 | 3.825 |
| 11:02 ET | 1396 | 3.825 |
| 11:04 ET | 3426 | 3.835 |
| 11:06 ET | 3544 | 3.808 |
| 11:08 ET | 100 | 3.805 |
| 11:09 ET | 1682 | 3.79 |
| 11:11 ET | 585 | 3.79 |
| 11:13 ET | 200 | 3.795 |
| 11:15 ET | 726 | 3.795 |
| 11:18 ET | 1626 | 3.795 |
| 11:20 ET | 500 | 3.795 |
| 11:22 ET | 500 | 3.795 |
| 11:24 ET | 600 | 3.795 |
| 11:26 ET | 5668 | 3.805 |
| 11:27 ET | 803 | 3.81 |
| 11:29 ET | 924 | 3.805 |
| 11:31 ET | 526 | 3.805 |
| 11:33 ET | 900 | 3.805 |
| 11:36 ET | 8309 | 3.8 |
| 11:38 ET | 200 | 3.79 |
| 11:40 ET | 400 | 3.79 |
| 11:42 ET | 103 | 3.79 |
| 11:44 ET | 700 | 3.795 |
| 11:45 ET | 2609 | 3.81 |
| 11:47 ET | 2600 | 3.805 |
| 11:49 ET | 3057 | 3.815 |
| 11:51 ET | 500 | 3.815 |
| 11:54 ET | 588 | 3.815 |
| 11:56 ET | 555 | 3.81 |
| 11:58 ET | 7889 | 3.845 |
| 12:00 ET | 3301 | 3.855 |
| 12:02 ET | 200 | 3.86 |
| 12:03 ET | 200 | 3.86 |
| 12:05 ET | 2705 | 3.86 |
| 12:07 ET | 7613 | 3.84 |
| 12:09 ET | 900 | 3.845 |
| 12:12 ET | 100 | 3.845 |
| 12:14 ET | 504 | 3.84 |
| 12:16 ET | 500 | 3.84 |
| 12:18 ET | 1451 | 3.845 |
| 12:20 ET | 100 | 3.845 |
| 12:21 ET | 4919 | 3.835 |
| 12:23 ET | 4200 | 3.835 |
| 12:25 ET | 337 | 3.835 |
| 12:27 ET | 4555 | 3.845 |
| 12:30 ET | 300 | 3.845 |
| 12:32 ET | 300 | 3.85 |
| 12:34 ET | 1200 | 3.85 |
| 12:36 ET | 7028 | 3.83 |
| 12:38 ET | 918 | 3.835 |
| 12:39 ET | 2932 | 3.845 |
| 12:41 ET | 157 | 3.845 |
| 12:45 ET | 3067 | 3.86 |
| 12:48 ET | 600 | 3.855 |
| 12:50 ET | 1304 | 3.85 |
| 12:52 ET | 3618 | 3.845 |
| 12:54 ET | 4169 | 3.855 |
| 12:56 ET | 418 | 3.855 |
| 12:57 ET | 1566 | 3.845 |
| 12:59 ET | 400 | 3.84 |
| 01:01 ET | 500 | 3.85 |
| 01:03 ET | 5201 | 3.865 |
| 01:06 ET | 636 | 3.86 |
| 01:08 ET | 200 | 3.865 |
| 01:10 ET | 575 | 3.86 |
| 01:12 ET | 5603 | 3.885 |
| 01:14 ET | 25542 | 3.9097 |
| 01:15 ET | 300 | 3.91 |
| 01:17 ET | 3452 | 3.92 |
| 01:19 ET | 200 | 3.915 |
| 01:21 ET | 3966 | 3.915 |
| 01:24 ET | 8386 | 3.919 |
| 01:26 ET | 9656 | 3.925 |
| 01:28 ET | 12331 | 3.935 |
| 01:30 ET | 500 | 3.935 |
| 01:32 ET | 802 | 3.94 |
| 01:33 ET | 2898 | 3.945 |
| 01:35 ET | 9356 | 3.93 |
| 01:37 ET | 6869 | 3.93 |
| 01:42 ET | 12878 | 3.925 |
| 01:44 ET | 536 | 3.925 |
| 01:46 ET | 3924 | 3.93 |
| 01:48 ET | 1257 | 3.93 |
| 01:50 ET | 430 | 3.925 |
| 01:51 ET | 3152 | 3.925 |
| 01:53 ET | 2750 | 3.935 |
| 01:55 ET | 857 | 3.9374 |
| 01:57 ET | 100 | 3.94 |
| 02:00 ET | 300 | 3.93 |
| 02:02 ET | 5728 | 3.935 |
| 02:04 ET | 3642 | 3.9411 |
| 02:06 ET | 357 | 3.945 |
| 02:08 ET | 200 | 3.94 |
| 02:09 ET | 3051 | 3.935 |
| 02:11 ET | 400 | 3.935 |
| 02:13 ET | 2824 | 3.945 |
| 02:15 ET | 100 | 3.945 |
| 02:18 ET | 8295 | 3.95 |
| 02:20 ET | 300 | 3.945 |
| 02:22 ET | 3013 | 3.955 |
| 02:24 ET | 500 | 3.96 |
| 02:26 ET | 944 | 3.95 |
| 02:27 ET | 4533 | 3.96 |
| 02:29 ET | 300 | 3.955 |
| 02:31 ET | 1045 | 3.955 |
| 02:33 ET | 2594 | 3.955 |
| 02:36 ET | 6286 | 3.945 |
| 02:38 ET | 593 | 3.945 |
| 02:40 ET | 31027 | 3.945 |
| 02:42 ET | 1129 | 3.945 |
| 02:44 ET | 2363 | 3.94 |
| 02:45 ET | 4583 | 3.94 |
| 02:47 ET | 32729 | 3.92 |
| 02:49 ET | 300 | 3.91 |
| 02:51 ET | 5765 | 3.9 |
| 02:54 ET | 8024 | 3.895 |
| 02:56 ET | 2052 | 3.885 |
| 02:58 ET | 1845 | 3.88 |
| 03:00 ET | 13500 | 3.88 |
| 03:02 ET | 3527 | 3.88 |
| 03:03 ET | 5896 | 3.88 |
| 03:05 ET | 11969 | 3.88 |
| 03:07 ET | 3514 | 3.885 |
| 03:09 ET | 1400 | 3.885 |
| 03:12 ET | 19970 | 3.905 |
| 03:14 ET | 9010 | 3.91 |
| 03:18 ET | 812 | 3.91 |
| 03:20 ET | 2425 | 3.91 |
| 03:21 ET | 4883 | 3.915 |
| 03:23 ET | 1248 | 3.915 |
| 03:25 ET | 1264 | 3.915 |
| 03:27 ET | 1296 | 3.91 |
| 03:30 ET | 1400 | 3.91 |
| 03:32 ET | 2581 | 3.915 |
| 03:34 ET | 731 | 3.92 |
| 03:36 ET | 22535 | 3.905 |
| 03:38 ET | 1834 | 3.905 |
| 03:39 ET | 10324 | 3.9 |
| 03:41 ET | 9040 | 3.905 |
| 03:43 ET | 1406 | 3.905 |
| 03:45 ET | 3800 | 3.905 |
| 03:48 ET | 3399 | 3.905 |
| 03:50 ET | 11293 | 3.9 |
| 03:52 ET | 22484 | 3.915 |
| 03:54 ET | 24250 | 3.935 |
| 03:56 ET | 40807 | 3.905 |
| 03:57 ET | 31675 | 3.89 |
| 03:59 ET | 330918 | 3.89 |
Jun 4, 2024
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4), from 4:01PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:01PM ET on Tuesday Jun 04, 2024 by Dow Jones
May 29, 2024
Fate Therapeutics to Present at 2024 Jefferies Global Healthcare Conference, from 4:01PM ET on Wednesday May 29, 2024 by Dow Jones
4:01PM ET on Wednesday May 29, 2024 by Dow Jones
May 16, 2024
DJ Fate Therapeutics Is Maintained at Neutral by HC Wainwright & Co., from 7:49AM ET on Thursday May 16, 2024 by Dow Jones
7:49AM ET on Thursday May 16, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fate Therapeutics Inc | 439.4M | -2.0x | --- |
Editas Medicine Inc | 437.5M | -2.6x | --- |
Contineum Therapeutics Inc | 461.0M | 21.0x | --- |
ADC Therapeutics SA | 350.1M | -1.1x | --- |
Urogen Pharma Ltd | 461.4M | -3.9x | --- |
MacroGenics Inc | 286.9M | -13.1x | --- |
Company Information
Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is dedicated to bringing a pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Its proprietary induced pluripotent stem cells (iPSC) product platform combines multiplexed-engineering of human iPSCs with single-cell selection to create clonal master iPSC lines. The Company’s platform is designed to overcome numerous limitations associated with the manufacture of cell therapies using patient- or donor-sourced cells. Utilizing its proprietary iPSC product platform, it is advancing off-the-shelf, multiplexed-engineered natural killer (NK) cell and T-cell product candidates which are selectively designed, incorporate novel synthetic controls of cell function. Its pipeline of iPSC-derived, chimeric antigen receptor (CAR)-targeted NK cell and T-cell product candidates include FT819, FT522, FT576, FT825, FT819, FT522, and others.
Contact Information
- Headquarters
- 12278 Scripps Summit DriveSAN DIEGO, CA, United States 92131
- Phone
- 858-875-1803
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- William Rastetter
- President, Chief Executive Officer, Chief Financial Officer, Principal Financial and Accounting Officer, Director
- John Wolchko
- Independent Vice Chairman of the Board
- John Mendlein
- Chief Financial Officer
- Edward Dulac
- General Counsel, Corporate Secretary
- Cindy Tahl
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $439.4M |
|---|---|
Revenue (TTM) | $6.5M |
Shares Outstanding | 113.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.92 |
EPS | $-1.92 |
Book Value | $3.74 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 67.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,287.85% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
